The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Moving beyond CAR T-cell therapy: Why is everyone talking about NK-cell therapy?

During the European School of Haematology (ESH) 3rd How to Diagnose and Treat Multiple Myeloma conference, the Multiple Myeloma Hub spoke to Nina Shah, UCSF, San Francisco, US. We asked, Why is everyone talking about NK-cell therapy?

Moving beyond CAR T-cell therapy: Why is everyone talking about NK-cell therapy?

In this video, Shah discusses the development of novel natural killer (NK)-cell therapies, and the benefits they may be able to offer to patients with multiple myeloma in the future.

Share: